V. Bryan Lawlis - Apr 14, 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Director
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Apr 14, 2022
Transactions value $
-$196,350
Form type
4
Date filed
4/18/2022, 08:22 PM
Previous filing
Jan 19, 2022
Next filing
May 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Options Exercise $159K +4.25K +17.73% $37.46 28.2K Apr 14, 2022 Direct F1
transaction BMRN Common Stock Sale -$356K -4.25K -15.06% $83.66 24K Apr 14, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to buy Common Stock) Options Exercise $0 -4.25K -100% $0.00* 0 Apr 14, 2022 Common Stock 4.25K $37.46 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Trade made pursuant to a 10b5-1 plan executed on July 29, 2021.
F2 Reflects the number of options outstanding after the transactions from this specific stock option grant.